Insufficient scRNA-seq data for expression of ZGLP1 at single-cell level.
Insufficient scRNA-seq data for expression of ZGLP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 668.90 | 2609 / 2642 | 85% | 2.32 | 600 / 705 |
thymus | 100% | 890.64 | 653 / 653 | 83% | 2.39 | 500 / 605 |
prostate | 99% | 665.47 | 243 / 245 | 61% | 1.37 | 305 / 502 |
uterus | 99% | 310.07 | 168 / 170 | 58% | 1.32 | 265 / 459 |
bladder | 100% | 271.62 | 21 / 21 | 43% | 0.93 | 218 / 504 |
ovary | 99% | 447.47 | 178 / 180 | 44% | 0.90 | 190 / 430 |
pancreas | 91% | 174.91 | 297 / 328 | 46% | 0.82 | 82 / 178 |
adrenal gland | 78% | 132.41 | 202 / 258 | 55% | 3.56 | 127 / 230 |
breast | 92% | 233.98 | 422 / 459 | 34% | 0.66 | 382 / 1118 |
liver | 98% | 324.57 | 222 / 226 | 25% | 0.46 | 103 / 406 |
kidney | 100% | 447.84 | 89 / 89 | 23% | 0.38 | 205 / 901 |
lung | 89% | 232.21 | 512 / 578 | 30% | 0.50 | 347 / 1155 |
intestine | 96% | 236.57 | 925 / 966 | 19% | 0.32 | 102 / 527 |
skin | 89% | 161.32 | 1617 / 1809 | 25% | 0.39 | 117 / 472 |
spleen | 100% | 488.49 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.58 | 1 / 1 |
stomach | 82% | 134.30 | 295 / 359 | 12% | 0.20 | 35 / 286 |
esophagus | 84% | 170.24 | 1215 / 1445 | 10% | 0.14 | 18 / 183 |
lymph node | 0% | 0 | 0 / 0 | 93% | 2.82 | 27 / 29 |
adipose | 84% | 157.46 | 1006 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 69% | 114.37 | 644 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 60% | 84.36 | 800 / 1335 | 0% | 0 | 0 / 0 |
heart | 50% | 72.20 | 434 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 40% | 0.82 | 18 / 45 |
muscle | 35% | 47.25 | 280 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 9% | 0.13 | 7 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048599 | Biological process | oocyte development |
GO_0007283 | Biological process | spermatogenesis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0008270 | Molecular function | zinc ion binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
Gene name | ZGLP1 |
Protein name | GATA-type zinc finger protein 1 (GATA-like protein 1) (GLP-1) Zinc finger GATA like protein 1 |
Synonyms | GLP1 |
Description | FUNCTION: Transcriptional regulator that plays a key role in germ cell development. Determines the oogenic fate by activating key genes for the oogenic program and meiotic prophase entry. Acts downstream of bone morphogenetic protein (BMP) by regulating expression of genes required for the oogenic programs, which are repressed by Polycomb activities in sexually uncommitted germ cells. Regulates expression of STRA8, a central downstream effector for the meiotic program. Acts independently of retinoic acid (RA). In males, not required for germ-cell sex determination, but required to allow the spermatogonia to efficiently accomplish the meiotic prophase. . |
Accessions | A0A9L9PXT6 P0C6A0 ENST00000707000.1 ENST00000403903.7 B5MCP8 ENST00000403352.1 |